| Allostatic load and subsequent all-cause mortality: which biological markers drive the relationship? Findings from a UK birth cohort R Castagné, V Garès, M Karimi, M Chadeau-Hyam, P Vineis, C Delpierre, ... European journal of epidemiology 33, 441-458, 2018 | 122 | 2018 |
| Multi-cohort study identifies social determinants of systemic inflammation over the life course E Berger, R Castagné, M Chadeau-Hyam, M Bochud, A d’Errico, ... Nature communications 10 (1), 773, 2019 | 95 | 2019 |
| Multicenter evaluation of breast cancer patients’ satisfaction and experience with oncology telemedicine visits during the COVID-19 pandemic A Bizot, M Karimi, E Rassy, PE Heudel, C Levy, L Vanlemmens, C Uzan, ... British journal of cancer 125 (11), 1486-1493, 2021 | 55 | 2021 |
| Education, biological ageing, all-cause and cause-specific mortality and morbidity: UK biobank cohort study M Chadeau-Hyam, B Bodinier, R Vermeulen, M Karimi, V Zuber, ... EClinicalMedicine, 2020 | 40 | 2020 |
| Early-life inequalities and biological ageing: a multisystem Biological Health Score approach in Understanding Society M Karimi, R Castagné, C Delpierre, G Albertus, E Berger, P Vineis, ... J Epidemiol Community Health, 2019 | 38 | 2019 |
| Socioprofessional trajectories and mortality in France, 1976–2002: a longitudinal follow-up of administrative data M Karimi, B Geoffroy-Perez, A Fouquet, A Latouche, G Rey J Epidemiol Community Health 69 (4), 339-346, 2015 | 16 | 2015 |
| Agnostic Cys34‐albumin adductomics and DNA methylation: Implication of N‐acetylcysteine in lung carcinogenesis years before diagnosis S Dagnino, B Bodinier, H Grigoryan, SM Rappaport, M Karimi, F Guida, ... International Journal of Cancer 146 (12), 3294-3303, 2020 | 15 | 2020 |
| Prognostic and predictive effect of KRAS gene copy number and mutation status in early stage non-small cell lung cancer patients AS Fung, M Karimi, S Michiels, L Seymour, E Brambilla, T Le-Chevalier, ... Translational Lung Cancer Research 10 (2), 826, 2021 | 10 | 2021 |
| Axillary Reverse Mapping Using Near-infrared fluorescence Imaging in Invasive Breast Cancer (ARMONIC study) A Conversano, M Abbaci, M Karimi, MC Mathieu, F de Leeuw, S Michiels, ... European Journal of Surgical Oncology, 2022 | 7 | 2022 |
| Comprehensive Genome Profiling in Patients With Metastatic Non–Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung Trial F Barlesi, P Tomasini, M Karimi, S Michiels, J Raimbourg, C Daniel, ... Clinical Cancer Research 28 (18), 4018-4026, 2022 | 6 | 2022 |
| Epigenetic mechanisms of lung carcinogenesis involve differentially methylated CpG sites beyond those associated with smoking D Petrovic, B Bodinier, S Dagnino, M Whitaker, M Karimi, G Campanella, ... European Journal of Epidemiology 37 (6), 629-640, 2022 | 6 | 2022 |
| Molecular profiling of non-small-cell lung cancer patients with or without brain metastases included in the randomized SAFIR02-LUNG trial and association with intracranial outcome A Mogenet, F Barlesi, B Besse, S Michiels, M Karimi, A Tran-Dien, ... Lung Cancer 169, 31-39, 2022 | 4 | 2022 |
| Near-infrared fluorescence axillary reverse mapping (ARM) procedure in invasive breast cancer: relationship between fluorescence signal in ARM lymph nodes and clinical outcomes M Abbaci, A Conversano, M Karimi, MC Mathieu, V Rouffiac, F De Leeuw, ... Cancers 14 (11), 2614, 2022 | 3 | 2022 |
| Evaluation of the satisfaction and experiences of oncology patients and doctors using teleconsultation during the COVID-19 pandemic M Kastrisiou, M Karimi, EAA Christou, A Bizot, MA Ropers, A De-Jesus, ... Journal of Telemedicine and Telecare, 1357633X241229462, 2024 | 2 | 2024 |
| Association of Molecular Profiles and Mutational Status With Distinct Histological Lung Adenocarcinoma Subtypes. An Analysis of the LACE-Bio Data PA Kumar, M Karimi, A Basnet, L Seymour, R Kratzke, E Brambilla, ... Clinical Lung Cancer 24 (6), 528-540, 2023 | 2 | 2023 |
| Maintenance targeted therapy compared to standard of care (SoC) in patients (pts) with metastatic non-small cell lung cancer (NSCLC): Results from the phase II randomized … B Besse, M Karimi, P Tomasini, H Janicot, J Raimbourg, ... Journal of Clinical Oncology 39 (15_suppl), 9095-9095, 2021 | 2 | 2021 |
| Association of ctDNA tumor fraction with survival in advanced non-small cell lung cancer (NSCLC) treated with maintenance durvalumab in the UNICANCER SAFIR02-Lung/IFCT1301 trial. FG Dall'Olio, D Vasseur, M Karimi, S Michiels, L Lacroix, P Tomasini, ... Journal of Clinical Oncology 41 (16_suppl), 2516-2516, 2023 | 1 | 2023 |
| 1273P Durvalumab (D) compared to maintenance chemotherapy (SoC) in patients (pts) with metastatic non-small cell lung cancer (NSCLC): Results from the randomized SAFIR02 LUNG … F Barlesi, M Karimi, P Tomasini, C Daniel, J Raimbourg, AE Quoix, ... Annals of Oncology 31, S823, 2020 | 1 | 2020 |
| 1710P International multicentric evaluation of breast cancer patients’ satisfaction and experience with oncology telemedicine visits (TV) during the COVID-19 outbreak A Bizot, PE Heudel, M Karimi, C Levy, L Vanlemmens, C Uzan, E Deluche, ... Annals of Oncology 31, S1006, 2020 | 1 | 2020 |
| Social patterning of inflammation over the lifecourse and its relationship with mortality: Raphaële Castagné R Castagné, M Chadeau-Hyam, M Karimi, S Stringhini, P Vineis, ... European Journal of Public Health 29 (Issue Supplement_4), 2019 | 1 | 2019 |
Michelle Kelly-IrvingDirector of research, INSERMVerified email at inserm.fr
